NovaBridge Biosciences (NBP): SEC Form 3 filed by new insider Liu Xin
Stocks in this Quantisnow insightHealth Care
Historical context for NBP
Across the 12 sessions after earlier NBP headlines, the stock closed higher 8 times and lower 4 times, with a median move of 3.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NBP | SPY |
|---|---|---|---|
| Mar 16, 2026 | NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer | +2.5% | +1.0% |
| Mar 9, 2026 | NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study | +0.1% | +0.9% |
| Mar 3, 2026 | NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 | -7.2% | -0.9% |
| Mar 2, 2026 | NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference | +5.2% | +0.1% |
| Feb 19, 2026 | NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform | +0.9% | -0.3% |
| Feb 18, 2026 | NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer | +2.2% | +0.5% |
Keep researching NBP
- NBP insider tradesEvery buy and sale reported by NovaBridge Biosciences officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NBP earnings historyPast NovaBridge Biosciences earnings releases, newest first.
- NBP financial statementsRevenue, profit, cash flow and balance sheet from NovaBridge Biosciences's SEC filings.
Quantisnow market dataNASDAQ
NBP
NovaBridge Biosciences
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for NBP
Full NBP profile on Quantisnow Follow NBP and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time